Infectious Disease & Vaccines

For decades, researchers have tried to craft a successful vaccine for HIV. mRNA vaccines may offer the answer.

Chagas disease stems from a parasitic infection. Now, with the help of a few insect-eating monkeys, a new treatment for this condition is on the horizon.

Oral vaccines stop pathogens in their tracks before they get a chance to cause disease.

Menstrual toxic shock syndrome remains a life-threatening disease, so researchers are exploring safer tampon designs, toxin neutralization, and vaccination.

Robert Georgantas aims to expand the development of mRNA-based vaccines for a range of infectious diseases and cancers.

Researchers discovered how SARS-CoV-2 invades and spreads through nasal epithelial cells, identifying potential new drug targets to prevent transmission.

Vaginal dysbiosis has long been a taboo subject, but studying and optimizing the vaginal microbiome could be a game changer for women’s health.

As the antibiotic resistance crisis grows, scientists eye a predatory bacterium as a potential therapeutic.

In vitro transcription lays the foundation for recent advances in mRNA vaccines and therapeutics. 

Fragile mRNA molecules depend on protective carriers to transport them into cells. 

Tardigrades survive heat, freezing, and even space radiation. Now, researchers translate lessons learned from these creatures into more stable drug formulations and new health insights.

By engineering a probiotic with tiny antibodies from alpacas, scientists created a potential new oral tool to treat deadly diarrheal infections.